Atara Biotherapeutics Inc - Company Profile
Powered by
All the data and insights you need on Atara Biotherapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Atara Biotherapeutics Inc Strategy Report
- Understand Atara Biotherapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Atara Biotherapeutics Inc (Atara) is one of the leading T-cell immunotherapy companies that focuses on development of innovative treatments for cancer, and other autoimmune diseases and viral diseases. Its T-cell immunotherapies identify and eradicate cancerous cells without affecting healthy cells. Lead Product Candidate: Tabelecleucel, or Tab-cel, focus on R&D, and increased license and collaboration revenue are its strengths even as history of operating losses is a cause of concern for the company. Atara could regulatory approval, unmet clinical need for EBV associated infections, and strategic initiatives. However, high competition, rapid technological changes and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer